Early acid-base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis

Rinaldo Bellomo, Miklos Lipcsey, Paolo Calzavacca, Michael Haase, Anja Haase-Fielitz, Elisa Licari, Augustine Tee, Louise Cole, Alan Cass, Simon R Finfer, Martin Patrick Gallagher, Joanne Lee, Serigne Lo, Colin McArthur, Shay P McGuinness, John A Myburgh, Carlos D Scheinkestel

Research output: Contribution to journalArticleResearchpeer-review

33 Citations (Scopus)


Purpose: In acute kidney injury patients, metabolic acidosis is common. Its severity, duration, and associated changes in mean arterial pressure (MAP) and vasopressor therapy may be affected by the intensity of continuous renal replacement therapy (CRRT). We aimed to compare key aspects of acidosis and MAP and vasopressor therapy in patients treated with two different CRRT intensities. Methods: We studied a nested cohort of 115 patients from two tertiary intensive care units (ICUs) within a large multicenter randomized controlled trial treated with lower intensity (LI) or higher intensity (HI) CRRT. Results: Levels of metabolic acidosis at randomization were similar [base excess (BE) of -8 ? 8 vs. -8 ? 7 mEq/l; p = 0.76]. Speed of BE correction did not differ between the two groups. However, the HI group had a greater increase in MAP from baseline to 24 h (7 ? 3 vs. 0 ? 3 mmHg; p <0.01) and a greater decrease in norepinephrine dose (from 12.5 to 3.5 vs. 5 to 2.5 ?g/min; p <0.05). The correlation (r) coefficients between absolute change in MAP and norepinephrine (NE) dose versus change in BE were 0.05 and -0.37, respectively. Conclusions: Overall, LI and HI CRRT have similar acid-base effects in patients with acidosis. However, HI was associated with greater improvements in MAP and vasopressor requirements (clinical trial no. NCT00221013).
Original languageEnglish
Pages (from-to)429-436
Number of pages8
JournalIntensive Care Medicine
Publication statusPublished - 2013
Externally publishedYes

Cite this